Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Rivaroxaban with Cobicistat or Darunavir/Cobicistat in Healthy Participants

Lilian W. Adeojo, Cheryl Pauls, Doris Swaim, Parag Kumar, Haden T. Bun, Alice Pau, Safia Kuriakose, Khanh Nghiem, Alina Dulau-Florea, Xiaobai Li, Yi Zeng, Cody J. Peer, William D. Figg, Colleen Hadigan, Jomy M. George

Open source

DOI: 10.1097/qai.0000000000003971
Published: 2026-09-04
Container: JAIDS Journal of Acquired Immune Deficiency Syndromes
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/qai.0000000000003971,
  title = {Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Rivaroxaban with Cobicistat or Darunavir/Cobicistat in Healthy Participants},
  author = {Lilian W. Adeojo and Cheryl Pauls and Doris Swaim and Parag Kumar and Haden T. Bun and Alice Pau and Safia Kuriakose and Khanh Nghiem and Alina Dulau-Florea and Xiaobai Li and Yi Zeng and Cody J. Peer and William D. Figg and Colleen Hadigan and Jomy M. George},
  year = {2026},
  journal = {JAIDS Journal of Acquired Immune Deficiency Syndromes},
  doi = {10.1097/qai.0000000000003971},
  url = {https://doi.org/10.1097/qai.0000000000003971}
}

RIS

TY  - JOUR
TI  - Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Rivaroxaban with Cobicistat or Darunavir/Cobicistat in Healthy Participants
AU  - Lilian W. Adeojo
AU  - Cheryl Pauls
AU  - Doris Swaim
AU  - Parag Kumar
AU  - Haden T. Bun
AU  - Alice Pau
AU  - Safia Kuriakose
AU  - Khanh Nghiem
AU  - Alina Dulau-Florea
AU  - Xiaobai Li
AU  - Yi Zeng
AU  - Cody J. Peer
AU  - William D. Figg
AU  - Colleen Hadigan
AU  - Jomy M. George
PY  - 2026
JO  - JAIDS Journal of Acquired Immune Deficiency Syndromes
DO  - 10.1097/qai.0000000000003971
UR  - https://doi.org/10.1097/qai.0000000000003971
ER  -

APA

Adeojo, L. W., Pauls, C., Swaim, D., Kumar, P., Bun, H. T., Pau, A., Kuriakose, S., Nghiem, K., Dulau-Florea, A., Li, X., Zeng, Y., Peer, C. J., Figg, W. D., Hadigan, C., & George, J. M. (2026). Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Rivaroxaban with Cobicistat or Darunavir/Cobicistat in Healthy Participants. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/qai.0000000000003971

Source records

crossref · retrieved 2026-09-26T10:22:18.691Z